(Q40517202)

21 September 2017

1 reference

title

ANTISENSE oligonucleotides: a new tool in neuroscience (English)

1 reference

21 September 2017

Pilowsky PM

1

1 reference

21 September 2017

Suzuki S

series ordinal

2

1 reference

21 September 2017

Minson JB

series ordinal

3

1 reference

21 September 2017

publication date

1 December 1994

1 reference

Clinical and Experimental Pharmacology and Physiology

21 September 2017

published in

1 reference

21 September 2017

volume

21

1 reference

21 September 2017

issue

12

1 reference

21 September 2017

page(s)

935-944

1 reference

Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Antisense agents in pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Interleukin 1 induces beta-endorphin secretion via Fos and Jun in AtT-20 pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Antisense: into the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

A novel method to stabilise antisense oligonucleotides against exonuclease degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

A single amino acid exchange alters the pharmacology of neonatal rat glycine receptor subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Inhibition of Rab3B expression attenuates Ca(2+)-dependent exocytosis in rat anterior pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Characterization of oligonucleotide transport into living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Intracerebral administration of antisense oligodeoxynucleotides to GAD65 and GAD67 mRNAs modulate reproductive behavior in the female rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Current concepts in antisense drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Antisense oligonucleotide blocks progesterone-induced lordosis behavior in ovariectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

3' non-coding region sequences in eukaryotic messenger RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Capping of eucaryotic mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Ventral tegmental area (VTA) injections of tyrosine hydroxylase phosphorothioate antisense oligonucleotide suppress operant behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Translational suppression of a glutamate receptor subunit impairs long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Antisense oligonucleotide strategies in neuropharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Complete protection of antisense oligonucleotides against serum nuclease degradation by an avidin-biotin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

AUG is the only recognisable signal sequence in the 5′ non-coding regions of eukaryotic mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Adenine-rich Polymer associated with Rabbit Reticulocyte Messenger RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1994.TB02655.X

10.1111/J.1440-1681.1994.TB02655.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference